Amgen Inc.

AMGN · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

397 USD

Margin of Safety

+6.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Amgen is a leading biopharmaceutical company that generates revenues through research, development, manufacturing, and marketing of innovative biological therapeutics in the areas of oncology, cardiology, inflammatory diseases, and bone diseases.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.